He characterizes the cellular and molecular pathways that cause neurodegenerative disorders, specifically Huntington’s Disease (HD), by using the genetically tractable organism Dictyostelium (Dicty). To this end, he has developed a deficiency model in Dicty. Strains without the htt gene show that it is critical for processes have subsequently also been found to be altered in various mammalian models of HD.